Vanguard Group Inc Organogenesis Holdings Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,672,432 shares of ORGO stock, worth $13.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,672,432

Previous 3,562,710 3.08%

Holding current value

$13.5 Million

Previous $9.98 Million 5.29%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$2.42 - $3.24 $265,527 - $355,499	109,722 Added 3.08%	3,672,432 $10.5 Million
Q2 2024 Aug 13, 2024	BUY	$2.28 - $3.03 $62,497 - $83,055	27,411 Added 0.78%	3,562,710 $9.98 Million
Q1 2024 May 10, 2024	SELL	$2.61 - $4.49 $4.76 Million - $8.2 Million	-1,825,428 Reduced 34.05%	3,535,299 $10 Million
Q4 2023 Feb 14, 2024	BUY	$1.97 - $4.21 $3.28 Million - $7.01 Million	1,665,088 Added 45.06%	5,360,727 $21.9 Million
Q3 2023 Nov 14, 2023	BUY	$2.34 - $4.43 $161,916 - $306,533	69,195 Added 1.91%	3,695,639 $11.8 Million
Q2 2023 Aug 14, 2023	SELL	$1.9 - $4.3 $167,241 - $378,494	-88,022 Reduced 2.37%	3,626,444 $12 Million
Q1 2023 May 15, 2023	SELL	$1.89 - $2.93 $2.09 Million - $3.24 Million	-1,105,755 Reduced 22.94%	3,714,466 $7.91 Million
Q4 2022 Feb 10, 2023	BUY	$2.48 - $3.43 $844,648 - $1.17 Million	340,584 Added 7.6%	4,820,221 $13 Million
Q3 2022 Nov 14, 2022	BUY	$3.14 - $6.43 $862,404 - $1.77 Million	274,651 Added 6.53%	4,479,637 $14.5 Million
Q2 2022 Aug 12, 2022	SELL	$4.74 - $8.15 $1.9 Million - $3.26 Million	-400,271 Reduced 8.69%	4,204,986 $20.5 Million
Q1 2022 May 13, 2022	BUY	$6.47 - $9.57 $1.96 Million - $2.9 Million	303,243 Added 7.05%	4,605,257 $35.1 Million
Q4 2021 Feb 14, 2022	BUY	$9.02 - $13.5 $1.02 Million - $1.53 Million	112,990 Added 2.7%	4,302,014 $39.8 Million
Q3 2021 Nov 12, 2021	BUY	$13.71 - $17.18 $18.7 Million - $23.5 Million	1,365,400 Added 48.36%	4,189,024 $59.7 Million
Q2 2021 Aug 13, 2021	BUY	$14.92 - $23.23 $42.1 Million - $65.6 Million	2,823,624 New	2,823,624 $46.9 Million

Others Institutions Holding ORGO

# of Institutions

117

Shares Held

64.3M

Call Options Held

25K

Put Options Held

23.2K

View Full List

About Organogenesis Holdings Inc.

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $482M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

More about ORGO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Organogenesis Holdings Inc. Transaction History